"Because the conference is 100 percent virtual, attendees can experiencethe expo from the comfort of their own desks, saving their businessessignificant travel expenses and getting right to the industry informationand solutions they seek free of charge," said David Turek, Vice PresidentDeep Computing.

Leading scientists and researchers from industry, academia, and researchinstitutions will discuss how they are solving a wide range of challengingbiological, chemical, imaging, clinical, and interdisciplinary systemsproblems. These experts will share with attendees their use of breakthroughHigh Performance Computing (HPC) solution approaches that integrate newsoftware applications, systems, and sophisticated algorithms.

Selected speakers at the event and their topics include:

--  Dr. Paul Matsudaira, Director Whitehead Institute Professor of Biology    and Bioengineering, MIT, Advanced Imaging and Informatics Methods for    Complex Life Sciences Problems--  Professor Jan-Eric Litton, Director of Informatics, Karolinska    Institute, Biobanking - The Challenge of Infrastructure for Large Scale    Population Studies--  Dr. Joel Saltz, Professor and Chair, Department of BioMedical    Informatics, Ohio State University, The Cancer Biomedical Informatics Grid    (caBIG(TM))--  Dr. Ajay Royyuru, IBM Research, Computation Biology at IBM, Update on    the IBM Genealogy Project co-sponsored with National Geographic--  Dr. Michael Hehenberger, Solutions Executive, Global Life Sciences, IT    Architectures and Solutions for Imaging Biomarkers    

Free registration for this event is available at:http://vts.inxpo.com/scripts/Lightning.dll?LASCmd=AI:4;F:QS!10100&ShowKey=1129&AffiliateKey=526. Participants will receive a final agenda and fulllist of speakers prior to the event.

IBM has a long history of active collaboration with leading life sciencesapplications developers and researchers. The company's industry's leadingportfolio for Deep Computing andHPC systems and architectures ranging from the Cluster System 1350(TM)to the Blue Gene® solution are used throughout the life sciences industryfor bioinformatics, biochemistry, medical imaging and analysis, as well asclinical development.

IBM is also leading in the development of the next evolutionary phase ofthe Internet, helping clients and partners to conduct business insidevirtual worlds and to connect the virtual world with the real world througha richer, more immersive Web environment. As demonstrated by the LifeSciences Virtual Conference and Expo, IBM is experimenting with innovativecompanies across a variety of industries from healthcare & life sciences tobanking and insurance and from retail to media & entertainment.

For more information, please visit www.ibm.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine